Understanding the complexity and diversity of the immune context of the tumor microenvironment is essential to harness the immune system against these cancers, however, little is known about the heterogeneity of TIME due to the rarity of ALK-rearrangement in LCNEC. This evidence concerns the gene ALK and cancer.